Translating cancer genomics into precision medicine with artificial intelligence: applications, challenges and future perspectives

J Xu, P Yang, S Xue, B Sharma, M Sanchez-Martin… - Human genetics, 2019 - Springer
In the field of cancer genomics, the broad availability of genetic information offered by next-
generation sequencing technologies and rapid growth in biomedical publication has led to …

An integrated approach to unravel hidradenitis suppurativa etiopathogenesis

PM Tricarico, M Boniotto, G Genovese… - Frontiers in …, 2019 - frontiersin.org
Hidradenitis suppurativa/acne inversa (HS) is a chronic inflammatory disease involving hair
follicles that presents with painful nodules, abscesses, fistulae, and hypertrophic scars …

Clinical implications of aberrant PD-1 and CTLA4 expression for cancer immunity and prognosis: a pan-cancer study

JN Liu, XS Kong, T Huang, R Wang, W Li… - Frontiers in …, 2020 - frontiersin.org
Combination therapy with inhibitors of cytotoxic T lymphocyte-associated protein (CTLA) 4
and programmed death (PD)-1 has demonstrated efficacy in cancer patients. However, there …

DORGE: Discovery of Oncogenes and tumoR suppressor genes using Genetic and Epigenetic features

J Lyu, JJ Li, J Su, F Peng, YE Chen, X Ge, W Li - Science advances, 2020 - science.org
Data-driven discovery of cancer driver genes, including tumor suppressor genes (TSGs) and
oncogenes (OGs), is imperative for cancer prevention, diagnosis, and treatment. Although …

Pan-cancer mapping of differential protein-protein interactions

G Gulfidan, B Turanli, H Beklen, R Sinha, KY Arga - Scientific reports, 2020 - nature.com
Deciphering the variations in the protein interactome is required to reach a systems-level
understanding of tumorigenesis. To accomplish this task, we have considered the clinical …

NCAPG is a promising therapeutic target across different tumor types

C Xiao, J Gong, Y Jie, J Cao, Z Chen, R Li… - Frontiers in …, 2020 - frontiersin.org
Background With the advent of CRISPR-Cas9 genome editing tool in gene therapy,
identification of aberrantly expressed genes is of great value across various cancer types …

ECD-CDGI: An efficient energy-constrained diffusion model for cancer driver gene identification

T Wang, L Zhuo, Y Chen, X Fu, X Zeng… - PLOS Computational …, 2024 - journals.plos.org
The identification of cancer driver genes (CDGs) poses challenges due to the intricate
interdependencies among genes and the influence of measurement errors and noise. We …

[HTML][HTML] Pan-Cancer analysis of the expression and regulation of matrisome genes across 32 tumor types

V Izzi, J Lakkala, R Devarajan, A Kääriäinen… - Matrix Biology Plus, 2019 - Elsevier
The microenvironment plays a central role in cancer, and neoplastic cells actively shape it to
their needs by complex arrays of extracellular matrix (ECM) proteins, enzymes, cytokines …

Children's Oncology Group's 2023 blueprint for research: Germ cell tumors

R Bhuta, R Shah, JJ Gell, JN Poynter… - Pediatric blood & …, 2023 - Wiley Online Library
Extracranial germ cell tumors (GCT) are a biologically diverse group of tumors occurring in
children, adolescents, and young adults. The majority of patients have excellent outcomes …

Multi-approach bioinformatics analysis of curated omics data provides a gene expression panorama for multiple cancer types

BC Feltes, JF Poloni, IJG Nunes, SS Faria… - Frontiers in genetics, 2020 - frontiersin.org
Studies describing the expression patterns and biomarkers for the tumoral process increase
in number every year. The availability of new datasets, although essential, also creates a …